Patents by Inventor Frank Barry
Frank Barry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220407691Abstract: A system has a first non-transitory computer-readable medium storing a first program and a second non-transitory computer-readable medium storing a second program, the first program and second program including instructions that, when executed by one or more processors, execute a method of verifying a secure message tunnel during a communication session. The method includes: selecting a pseudo random byte string; breaking the pseudo random byte string into binary format; following the breaking the pseudo random byte string into binary format, transmitting a message between the first non-transitory computer-readable medium and the second non-transitory medium; following the transmitting the message, shifting a binary array associated with the pseudo random byte string and assigning a unique shift value to the message; determining the unique shift value has been reused; and responsive to the determining the unique shift value has been reused, breaking the session.Type: ApplicationFiled: August 17, 2022Publication date: December 22, 2022Inventors: Joshua Freeman Adams, David Patrick Forster, Frank Barry Robertson
-
Patent number: 11444761Abstract: A method of securely replacing a first data value with a second data value and related systems are disclosed. The method includes generating a first public key and a first private key, generating a cryptographic seed value, and passing the cryptographic seed value through an elliptic curve to generate a second public key and a second private key. The method further includes combining the first public key with the second private key using public key cryptography to create a shared encryption key and passing the shared encryption key through a symmetric algorithm to encrypt the cryptographic seed value.Type: GrantFiled: July 12, 2020Date of Patent: September 13, 2022Assignee: ETHOPASS, LLCInventors: Joshua Freeman Adams, David Patrick Forster, Frank Barry Robertson
-
Publication number: 20220141012Abstract: A method of securely replacing a first data value with a second data value and related systems are disclosed. The method includes generating a first public key and a first private key, generating a cryptographic seed value, and passing the cryptographic seed value through an elliptic curve to generate a second public key and a second private key. The method further includes combining the first public key with the second private key using public key cryptography to create a shared encryption key and passing the shared encryption key through a symmetric algorithm to encrypt the cryptographic seed value.Type: ApplicationFiled: July 12, 2020Publication date: May 5, 2022Inventors: Joshua Freeman Adams, David Patrick Forster, Frank Barry Robertson
-
Publication number: 20220103369Abstract: A method includes entropy hashing a hardened key; generating an asymmetric key pair from the hardened key; generating a keyspace chaincode from the hardened asymmetric key pair and the hardened key; and generating a verification key pair from the hardened asymmetric key pair. Related systems and methods are disclosed herein.Type: ApplicationFiled: February 3, 2020Publication date: March 31, 2022Inventors: Joshua Freeman Adams, David Patrick Forster, Frank Barry Robertson
-
Patent number: 9950016Abstract: The present invention relates to the use of secreted proteins from mesenchymal stem cells and other cells for the treatment of myocardial infarction. In particular, the invention provides compositions and methods based on secreted proteins from mesenchymal stem cells and the genes encoding them.Type: GrantFiled: June 25, 2012Date of Patent: April 24, 2018Assignee: NATIONAL UNIVERSITY OF IRELAND, GALWAYInventors: Timothy O'Brien, Frank Barry, Claire Kavanagh
-
Patent number: 9028953Abstract: CVD coated cutting tools are provided. A coated cutting tool described herein, in some embodiments, comprises a PcBN substrate and a polished coating adhered to the substrate including one or more layers of Al2O3 deposited by chemical vapor deposition, wherein the coating has a surface roughness (Ra) less than about 600 nm in an area of the cutting tool for contacting a workpiece.Type: GrantFiled: January 11, 2013Date of Patent: May 12, 2015Assignee: Kennametal Inc.Inventors: Frank Barry Battaglia, Crystal Jane Nestor, Peter Rudolf Leicht, Kent Lewis Reiner, Charles Graham McNerny
-
Publication number: 20140242142Abstract: The present invention relates to the use of secreted proteins from mesenchymal stem cells and other cells for the treatment of myocardial infarction. In particular, the invention provides compositions and methods based on secreted proteins from mesenchymal stem cells and the genes encoding them.Type: ApplicationFiled: June 25, 2012Publication date: August 28, 2014Applicant: National University of Ireland, GalwayInventors: Timothy O'Brien, Frank Barry, Claire Kavanagh
-
Publication number: 20140199130Abstract: CVD coated cutting tools are provided. A coated cutting tool described herein, in some embodiments, comprises a PcBN substrate and a polished coating adhered to the substrate including one or more layers of Al2O3 deposited by chemical vapor deposition, wherein the coating has a surface roughness (Ra) less than about 600 nm in an area of the cutting tool for contacting a workpiece.Type: ApplicationFiled: January 11, 2013Publication date: July 17, 2014Applicant: Kennametal Inc.Inventors: Frank Barry Battaglia, Crystal Jane Nestor, Peter Rudolf Leicht, Kent Lewis Reiner, Charles Graham McNerny
-
Patent number: 8617883Abstract: The Eph (erythropoietin-producing hepatocellular carcinoma) receptors and their cell surface anchored ligands, the Ephrins, comprise the largest of the receptor tyrosine kinases families with 14 receptors and 8 ligands. The receptors are subdivided into Eph-A and Eph-B categories and have known actions in the development of the vascular and nervous system. The present invention relates to an isolated mesenchymal stem cell selected from the group consisting of an isolated mesenchymal stem cell that expresses Ephrin-B2, an isolated mesenchymal stem cell that over-expresses Ephrin-B2, and an isolated mesenchymal stem cell that is genetically modified to increase Ephrin-B2 expression. The invention further relates to the various applications of the isolated mesenchymal stem cells of the present invention.Type: GrantFiled: July 31, 2008Date of Patent: December 31, 2013Assignee: National University of Ireland, GalwayInventors: Garry Paul Duffy, Frank Barry, Timothy O'Brien
-
Publication number: 20130037169Abstract: A liquid dispensing apparatus for filling at least one bottle with liquid is presented. The apparatus has an unfiltered water source, a filtration assembly, a dispensing assembly, and a bottle retention assembly. The dispensing assembly is configured to dispense filtered water into the interior volume of the at least one bottle.Type: ApplicationFiled: August 12, 2011Publication date: February 14, 2013Inventors: GARY VOLINO, Craig Cochran, Maureen Carroll, Jeff Juskowich, Frank Barry
-
Publication number: 20130007331Abstract: Details of a highly cost effective and efficient implementation of a manifold array (ManArray) architecture and instruction syntax for use therewith are described herein. Various aspects of this approach include the regularity of the syntax, the relative ease with which the instruction set can be represented in database form, the ready ability with which tools can be created, the ready generation of self-checking codes and parameterized test cases. Parameterizations can be fairly easily mapped and system maintenance is significantly simplified.Type: ApplicationFiled: September 12, 2012Publication date: January 3, 2013Applicant: ALTERA CORPORATIONInventors: Gerald G. Pechanek, David Carl Strube, Edwin Frank Barry, Charles W. Kurak, JR., Carl Donald Busboom, Dale Edward Schneider, Nikos P. Pitsianis, Grayson Morris, Edward A. Wolff, Patrick R. Marchand, Ricardo E. Rodriguez, Marco C. Jacobs
-
Patent number: 8323968Abstract: Osteopontin for the prediction and treatment of cardiovascular diseases The present invention relates to the use of endothelial progenitor cells (EPCs) and osteopontin for the treatment of cardiovascular diseases or complications. The invention also relates to the use of EPC osteopontin levels as a marker of the risk of the development of these cardiovascular complications. In particular, the invention provides compositions and methods based on osteopontin and the genes encoding osteopontin.Type: GrantFiled: March 3, 2008Date of Patent: December 4, 2012Assignee: National University of Ireland, GalwayInventors: Timothy O'Brien, Frank Barry, Aaron Yie Loong Liew, Afshin Samali, Angela Duffy
-
Publication number: 20120173849Abstract: Hardware and software techniques for interrupt detection and response in a scalable pipelined array processor environment are described. Utilizing these techniques, a sequential program execution model with interrupts can be maintained in a highly parallel scalable pipelined array processing containing multiple processing elements and distributed memories and register files. When an interrupt occurs, interface signals are provided to all PEs to support independent interrupt operations in each PE dependent upon the local PE instruction sequence prior to the interrupt. Processing/element exception interrupts are supported and low latency interrupt processing is also provided for embedded systems where real time signal processing is to required. Further, a hierarchical interrupt structure is used allowing a generalized debug approach using debut interrupts and a dynamic debut monitor mechanism.Type: ApplicationFiled: March 12, 2012Publication date: July 5, 2012Applicant: ALTERA CORPORATIONInventors: Edwin Frank Barry, Patrick R. Marchand, Gerald G. Pechanek, Larry D. Larsen
-
Patent number: 8117357Abstract: Details of a highly cost effective and efficient implementation of a manifold array (ManArray) architecture and instruction syntax for use therewith are described herein. Various aspects of this approach include the regularity of the syntax, the relative ease with which the instruction set can be represented in database form, the ready ability with which tools can be created, the ready generation of self-checking codes and parameterized test cases. Parameterizations can be fairly easily mapped and system maintenance is significantly simplified.Type: GrantFiled: May 12, 2011Date of Patent: February 14, 2012Assignee: Altera CorporationInventors: Gerald George Pechanek, David Carl Strube, Edwin Frank Barry, Charles W. Kurak, Jr., Carl Donald Busboom, Dale Edward Schneider, Nikos P. Pitsianis, Grayson Morris, Edward A. Wolff, Patrick R. Marchand, Ricardo E. Rodriguez, Marco C. Jacobs
-
Publication number: 20110219210Abstract: Details of a highly cost effective and efficient implementation of a manifold array (ManArray) architecture and instruction syntax for use therewith are described herein. Various aspects of this approach include the regularity of the syntax, the relative ease with which the instruction set can be represented in database form, the ready ability with which tools can be created, the ready generation of self-checking codes and parameterized test cases. Parameterizations can be fairly easily mapped and system maintenance is significantly simplified.Type: ApplicationFiled: May 12, 2011Publication date: September 8, 2011Applicant: ALTERA CORPORATIONInventors: Gerald G. Pechanek, David Carl Strube, Edwin Frank Barry, Charles W. Kurak, JR., Carl Donald Busboom, Dale Edward Schneider, Nikos P. Pitsianis, Grayson Morris, Edward A. Wolff, Patrick R. Marchand, Ricardo E. Rodriguez, Marco C. Jacobs
-
Publication number: 20110153890Abstract: A variety of advantageous mechanisms for improved data transfer control within a data processing system are described. A DMA controller is described which is implemented as a multiprocessing transfer engine supporting multiple transfer controllers which may work independently or in cooperation to carry out data transfers, with each transfer controller acting as an autonomous processor, fetching and dispatching DMA instructions to multiple execution units. In particular, mechanisms for initiating and controlling the sequence of data transfers are provided, as are processes for autonomously fetching DMA instructions which are decoded sequentially but executed in parallel.Type: ApplicationFiled: March 1, 2011Publication date: June 23, 2011Applicant: Altera CorporationInventors: Edwin Frank Barry, Edward A. Wolff
-
Patent number: 7962667Abstract: Details of a highly cost effective and efficient implementation of a manifold array (ManArray) architecture and instruction syntax for use therewith are described herein. Various aspects of this approach include the regularity of the syntax, the relative ease with which the instruction set can be represented in database form, the ready ability with which tools can be created, the ready generation of self-checking codes and parameterized test cases. Parameterizations can be fairly easily mapped and system maintenance is significantly simplified.Type: GrantFiled: July 12, 2007Date of Patent: June 14, 2011Inventors: Gerald G. Pechanek, David Carl Strube, Edwin Frank Barry, Charles W. Kurak, Jr., Carl Donald Busboom, Dale Edward Schneider, Nikos P. Pitsianis, Grayson Morris, Edward A. Wolff, Patrick R. Marchand, Ricardo E. Rodriguez, Marco C. Jacobs
-
Publication number: 20110072250Abstract: Hardware and software techniques for interrupt detection and response in a scalable pipelined array processor environment are described. Utilizing these techniques, a sequential program execution model with interrupts can be maintained in a highly parallel scalable pipelined array processing containing multiple processing elements and distributed memories and register files. When an interrupt occurs, interface signals are provided to all PEs to support independent interrupt operations in each PE dependent upon the local PE instruction sequence prior to the interrupt. Processing/element exception interrupts are supported and low latency interrupt processing is also provided for embedded systems where real time signal processing is required. Further, a hierarchical interrupt structure is used allowing a generalized debug approach using debut interrupts and a dynamic debut monitor mechanism.Type: ApplicationFiled: November 30, 2010Publication date: March 24, 2011Applicant: Altera CorporationInventors: Edwin Frank Barry, Patrick R. Marchand, Gerald G. Pechanek, Larry D. Larsen
-
Publication number: 20100150877Abstract: Osteopontin for the prediction and treatment of cardiovascular diseases The present invention relates to the use of endothelial progenitor cells (EPCs) and osteopontin for the treatment of cardiovascular diseases or complications. The invention also relates to the use of EPC osteopontin levels as a marker of the risk of the development of these cardiovascular complications. In particular, the invention provides compositions and methods based on osteopontin and the genes encoding osteopontin.Type: ApplicationFiled: March 3, 2008Publication date: June 17, 2010Applicant: NATIONAL UNIVERSITY OF IRELAND, GALWAYInventors: Timothy O'Brien, Frank Barry, Aaron Liew Yie Loong, Afshin Samali, Angela Duffy
-
Publication number: 20100062038Abstract: Abstract Markers, antibodies and recombinant scFvs for Mesenchymal Stem Cell sub-populations and osteoclasts. The present invention relates to specific epitopes of surface membrane bound glycoproteins expressed by mesenchymal stem cells and pre-osteoclasts and relates to antibodies such as monoclonal antibodies and recombinant scFv or fragments thereof, raised to the particular epitope and their use in identifying, isolating, and characterization of mesenchymal stem cell sub-populations such as that termed “Stromal Progenitor Cells” (SPCs) in bone marrow and identifying, isolating, and characterization of pre-osteoclasts in peripheral blood. By binding to a specific epitope on the cell surface, limbin/EVC-2 detection and separation by conventional cell sorting methodologies are facilitated.Type: ApplicationFiled: March 12, 2008Publication date: March 11, 2010Applicant: NATIONAL UNIVERSITY OF IRELAND, GALWAYInventors: Tyrone Villalard Bowes, Udo Greiser, William James Johnathan Finlay, Timothy O'Brien, Frank Barry